ATE465165T1 - Pyrimidothienindazole als tyrosinkinasehemmer des epidermalen wachstumsfaktors - Google Patents
Pyrimidothienindazole als tyrosinkinasehemmer des epidermalen wachstumsfaktorsInfo
- Publication number
- ATE465165T1 ATE465165T1 AT05851350T AT05851350T ATE465165T1 AT E465165 T1 ATE465165 T1 AT E465165T1 AT 05851350 T AT05851350 T AT 05851350T AT 05851350 T AT05851350 T AT 05851350T AT E465165 T1 ATE465165 T1 AT E465165T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrimidothienindazoles
- growth factor
- tyrosine kinase
- kinase inhibitors
- epidermal growth
- Prior art date
Links
- 102000009024 Epidermal Growth Factor Human genes 0.000 title 1
- 101800003838 Epidermal growth factor Proteins 0.000 title 1
- 229940116977 epidermal growth factor Drugs 0.000 title 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 title 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 title 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62264004P | 2004-10-27 | 2004-10-27 | |
| PCT/US2005/039901 WO2006055268A2 (en) | 2004-10-27 | 2005-10-26 | Pyrimidothienoindazoles capable of inhibiting tyrosine kinases of the epidermal growth factor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE465165T1 true ATE465165T1 (de) | 2010-05-15 |
Family
ID=36204347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05851350T ATE465165T1 (de) | 2004-10-27 | 2005-10-26 | Pyrimidothienindazole als tyrosinkinasehemmer des epidermalen wachstumsfaktors |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7511048B2 (de) |
| EP (1) | EP1819711B1 (de) |
| JP (1) | JP5070059B2 (de) |
| AT (1) | ATE465165T1 (de) |
| CA (1) | CA2585368A1 (de) |
| DE (1) | DE602005020836D1 (de) |
| ES (1) | ES2343196T3 (de) |
| WO (1) | WO2006055268A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2577664A1 (en) * | 2004-08-20 | 2006-03-02 | Bayer Pharmaceuticals Corporation | Novel heterocycles |
| ATE465165T1 (de) * | 2004-10-27 | 2010-05-15 | Bayer Schering Pharma Ag | Pyrimidothienindazole als tyrosinkinasehemmer des epidermalen wachstumsfaktors |
| JP2010006717A (ja) * | 2008-06-24 | 2010-01-14 | Kyorin Pharmaceut Co Ltd | ジヒドロチエノ［２，３−ｅ］インダゾール化合物 |
| WO2011077502A1 (ja) * | 2009-12-21 | 2011-06-30 | 杏林製薬株式会社 | ジヒドロチエノ［２，３－ｅ］インダゾール化合物 |
| CN105061461B (zh) * | 2015-08-18 | 2017-06-30 | 沈阳药科大学 | 含有苄胺结构的四氢苯并[4,5]噻吩并[2,3‑d]嘧啶类化合物及其应用 |
| CN105061460B (zh) * | 2015-08-18 | 2017-06-30 | 沈阳药科大学 | 含有硫醚结构的四氢苯并[4,5]噻吩并[2,3‑d]嘧啶类化合物及其应用 |
| AU2024256160A1 (en) | 2023-04-20 | 2025-10-02 | Amgen Inc. | Methods of determining relative unpaired glycan content |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL112248A0 (en) * | 1994-01-25 | 1995-03-30 | Warner Lambert Co | Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them |
| GB9520822D0 (en) * | 1995-10-11 | 1995-12-13 | Wellcome Found | Therapeutically active compounds |
| US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
| WO2002051849A1 (en) * | 2000-12-26 | 2002-07-04 | Daiichi Pharmaceutical Co., Ltd. | Cdk4 inhibitors |
| US6849638B2 (en) * | 2001-04-30 | 2005-02-01 | Bayer Pharmaceuticals Corporation | 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of pde7b-mediated diseases and conditions |
| CA2577664A1 (en) | 2004-08-20 | 2006-03-02 | Bayer Pharmaceuticals Corporation | Novel heterocycles |
| ATE465165T1 (de) * | 2004-10-27 | 2010-05-15 | Bayer Schering Pharma Ag | Pyrimidothienindazole als tyrosinkinasehemmer des epidermalen wachstumsfaktors |
-
2005
- 2005-10-26 AT AT05851350T patent/ATE465165T1/de not_active IP Right Cessation
- 2005-10-26 WO PCT/US2005/039901 patent/WO2006055268A2/en not_active Ceased
- 2005-10-26 JP JP2007539350A patent/JP5070059B2/ja not_active Expired - Fee Related
- 2005-10-26 ES ES05851350T patent/ES2343196T3/es not_active Expired - Lifetime
- 2005-10-26 CA CA002585368A patent/CA2585368A1/en not_active Abandoned
- 2005-10-26 EP EP05851350A patent/EP1819711B1/de not_active Expired - Lifetime
- 2005-10-26 DE DE602005020836T patent/DE602005020836D1/de not_active Expired - Lifetime
- 2005-10-26 US US11/666,362 patent/US7511048B2/en not_active Expired - Fee Related
-
2009
- 2009-03-30 US US12/414,183 patent/US20090186887A1/en not_active Abandoned
-
2010
- 2010-11-03 US US12/938,883 patent/US20110053928A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7511048B2 (en) | 2009-03-31 |
| JP5070059B2 (ja) | 2012-11-07 |
| WO2006055268A2 (en) | 2006-05-26 |
| DE602005020836D1 (de) | 2010-06-02 |
| US20090186887A1 (en) | 2009-07-23 |
| WO2006055268A3 (en) | 2006-08-03 |
| CA2585368A1 (en) | 2006-05-26 |
| JP2008518040A (ja) | 2008-05-29 |
| US20110053928A1 (en) | 2011-03-03 |
| EP1819711A2 (de) | 2007-08-22 |
| ES2343196T3 (es) | 2010-07-26 |
| EP1819711B1 (de) | 2010-04-21 |
| US20070299066A1 (en) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2009000128A1 (en) | Dihydropyridine derivatives useful as protein kinase inhibitors | |
| UA102251C2 (ru) | Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера | |
| MEP3808A (xx) | Derivati pirimidinil aril uree kao fgf inhibitori | |
| NO20071915L (no) | Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer | |
| SG178591A1 (en) | Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer | |
| MX2009009590A (es) | Aminopirimidinas utiles como inhibidores de proteinas cinasas. | |
| MXPA06011327A (es) | Azaindoles utiles como inhibidores de jak y otras proteinas cinasas. | |
| MX2010008719A (es) | Pirrolo [2,-d] piridinas y usos de las mismas como inhibidores de cinasa de tirosina. | |
| TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
| IL200793A0 (en) | Aminopyrimidines, compositions comprising the same and use thereof for inhibiting protein kinases | |
| ATE406351T1 (de) | Kondensierte heteroyralderivate zur verwendung als p38-kinase-inhibitoren | |
| EP1973407A4 (de) | Spiroverbindungen und anwendungsverfahren dafür | |
| TW200634012A (en) | 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents | |
| TW200716598A (en) | Aminoquinoline and aminoquinazoline kinase modulators | |
| MA32183B1 (fr) | Pyrimidylcyclopentanes hydroxylés utilisés comme inhibiteurs de protéine kinase akt | |
| TW200718693A (en) | Aminopyrimidines as kinase modulators | |
| TW200716118A (en) | Aminopyrimidines as kinase modulators | |
| EA200800017A1 (ru) | Алкилхинолиновые и алкилхиназолиновые модуляторы киназы | |
| TW200628153A (en) | Novel compounds | |
| UA87494C2 (en) | Azaindoles useful as inhibitors of jak and other protein kinases | |
| ATE465165T1 (de) | Pyrimidothienindazole als tyrosinkinasehemmer des epidermalen wachstumsfaktors | |
| TW200726763A (en) | Novel compound | |
| WO2006023843A3 (en) | Novel heterocycles | |
| MX2009011576A (es) | Nuevos derivados de 4,8-difenil-poliazanaftaleno. | |
| GB0514811D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |